Targeted Mental Health Admissions Position TMS as an FDA-cleared, non-invasive treatment for patients who have not achieved remission with antidepressants, highlighting a complementary option to expand care offerings and improve patient outcomes.

Expansion Potential With 51-200 employees and a focus on clinics in Pennsylvania, explore partnerships to scale referrals, joint marketing, and centralized scheduling to increase patient reach and treatment capacity.

Digital Marketing Leverage Leverage their existing tech stack (Google Ads, SEO tools) to propose performance marketing collaborations, lead generation programs, and conversion-optimized landing pages to boost patient inquiries.

Revenue Expansion Opportunities Despite current revenue in the low millions or less, there is room to offer turnkey practice enhancements, clinical training, or equipment financing to attract new clinics into a networked TMS model.

Competitive Positioning Differentiate through non-ECT, non-invasive treatment messaging and NeuroStar modality advantages to create co-marketing resources with similar players, and pursue exclusive or bundled offerings with hospitals or group practices.